Keywords: robert, agrylin, approved, hpb, roberts, pharmaceutical, received

Robert's Agrylin Approved By HPB

Article | 27 November 1997

- Roberts Pharmaceutical has received approval from Canada's HealthProtection Branch for Agrylin (anagrelide) for the treatment of essential thrombocythemia. The product ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Drugs

Agrylin

Anagrelide

Go to drug listing